nivolumab,ipilimumab
bms
['niche-2']
 this is a waterfall plot -myriam chalabi are you sure? never seen anything like this immune checkpoint inhibition in locally advanced mmr-deficient colon cancer: the niche-2 study neoadjuvant immunotherapy for the win! 
MD PhD. Oncologist at Oslo University Hospital. Medical oncology and cancer research. Mostly melanoma and immunotherapy. Private account. ????????????